Skip to main content
Premium Trial:

Request an Annual Quote

MRS to Include Markers in Software to Identify Myriad Test Candidates

NEW YORK (GenomeWeb News) – Myriad Genetics said today that Mammography Reporting Systems, a breast cancer tracking and reporting software service, will use risk markers to identify patients who might benefit from Myriad's BRACAnalysis test.

Myriad said that MRS will incorporate risk factors for hereditary breast cancer risk in its software, enabling more physicians at mammography screening centers to identify patients who may benefit from the Myriad test.

"Identifying high-risk patients will result in even better patient care," MRS CEO Mark Morris said in a statement. "Working in concert with the patients' primary care physician, radiologists who use
MRS software can identify and recommend increased surveillance and BRCA gene testing for those patients who are at high risk."

The Scan

Driving Malaria-Carrying Mosquitoes Down

Researchers from the UK and Italy have tested a gene drive for mosquitoes to limit the spread of malaria, NPR reports.

Office Space to Lab Space

The New York Times writes that some empty office spaces are transforming into lab spaces.

Prion Pause to Investigate

Science reports that a moratorium on prion research has been imposed at French public research institutions.

Genome Research Papers on Gut Microbe Antibiotic Response, Single-Cell RNA-Seq Clues to Metabolism, More

In Genome Research this week: gut microbial response to antibiotic treatment, approach to gauge metabolic features from single-cell RNA sequencing, and more.